MPMia Park

Mia Park

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mia Park has a total of 40 co-authors. Here are the top co-authors by number of shared publications:

  • Heon Jong Yoo

    Department of Obstetrics & Gynecology, Chungnam National University Sejong Hospital, Sejong, Korea

    6 shared publications
  • Byung Hun Kang

    Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea

    5 shared publications
  • Soo Youn Song

    Department of Obstetrics and Gynecology, Chungnam National University Sejong Hospital, 20 Bodeum 7-ro, Sejong 30099, Republic of Korea

    5 shared publications
  • Wonkyo Shin

    Department of Obstetrics and Gynecology, Chungnam National University Sejong Hospital, 20 Bodeum 7-ro, Sejong 30099, Republic of Korea

    5 shared publications
  • Mina Lee

    Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea

    4 shared publications
  • You Jin Kim

    Department of Obstetrics & Gynecology, Chungnam National University School of Medicine, 266 Munhwa-ro, Jung-gu, Daejeon 35015, Republic of Korea

    3 shared publications

Latest Publications

  • Open Access

    Postoperative Opioid-Free Multistep Opiranserin Infusion Versus Fentanyl Patient-Controlled Analgesia After Breast or Minimally Invasive Gynecologic Surgery: A Retrospective Cohort Study

    by Yeojung Kim, Mia Park, Sungho Choi, Juyeon Kim, Jinwoo Kim, Yeonsu Kim, Seounghun Lee, Chan Noh, Jiho Park

    Background/Objectives: Women undergoing breast or gynecologic surgery face high postoperative nausea and vomiting (PONV) risk, which often prompts discontinuation of opioid patient-controlled analgesia (PCA). Since anticipated opioid use is an Apfel risk factor, we examined a postoperative opioid-free analgesic regimen using opiranserin, previously evaluated only as an adjunct. Methods: In this single-center retrospective cohort study, 150 women undergoing breast or minimally invasive gynecologic surgery received a multistep opiranserin infusion via a PCA pump without demand boluses (n = 77) or fentanyl demand bolus PCA (n = 73). The opiranserin infusion ended at 10 h; fentanyl PCA remained connected throughout. The primary outcome was resting numeric rating scale (NRS, 0–10) at 24 h, by which time the infusion had been complete for 14–15 h; secondary outcomes were post-anesthesia care unit (PACU) and 6 h NRS, PONV, and early discontinuation. Results: Resting NRS did not differ significantly during the infusion (PACU p = 0.965; 6 h p = 0.675), with a larger difference at 24 h. The adjusted 24 h difference was 0.58 points higher with opiranserin (95% CI, 0.04 to 1.12; p = 0.036) by covariance analysis on pre-treatment covariates and 0.55 (0.02 to 1.09) by inverse-probability-of-treatment weighting; the point estimates were below the minimal clinically important difference of 1 point, but the confidence intervals do not exclude a clinically relevant increase in pain, and the estimate was nonsignificant after adjusting for non-opioid adjuncts (p = 0.177). Moderate or severe pain at 24 h was more frequent with opiranserin (19.5% vs. 8.2%; adjusted odds ratio, 3.76; 95% CI, 1.34 to 11.82). PONV (9.1% vs. 11.0%), rescue analgesia (26.0% vs. 17.8%), and early discontinuation (10.4% vs. 9.6%) were similar. Rescue opioids were available to both groups but used by one fentanyl-group patient and by none receiving opiranserin. Conclusions: The regimen eliminated postoperative opioid exposure, with resting pain scores that differed by less than 1 NRS point on average, although a clinically relevant increase cannot be excluded. With coverage fixed at 10 h, the 24 h difference cannot be separated into a shortfall of the agent and a shortfall of coverage. The anticipated PONV reduction was not observed, possibly in the context of low event rates and routine antiemetic prophylaxis.

  • Open Access

    Impact of Contrast-Enhanced Computed Tomography on the Management of Postpartum Hemorrhage with Extravasation

    by Suk Hwan Hyun, Byung Hun Kang, Hae Ri Kim, Ye Won Jung, Won Kyo Shin, Soo Youn Song, Jae Sung Choi, Young Bok Ko, Mina Lee, Mia Park, et al.

    Background: This study aimed to investigate the association of contrast extravasation (EV) detected on contrast-enhanced computed tomography (CE-CT) with the clinical characteristics, management, and outcomes of patients with postpartum hemorrhage (PPH). Methods: We retrospectively analyzed 51 patients with PPH who underwent CE-CT between August 2013 and July 2024. Patients were classified into EV (−) group (n = 28) and EV (+) group (n = 23). Baseline characteristics, management strategies, and clinical outcomes were compared. Results: The proportion of patients with a shock index (SI) ≥ 1.0 was significantly higher in the EV (+) group (10.7% vs. 39.1%, p = 0.017). Surgical intervention was more frequently required in the EV (+) group (10.7% vs. 56.5%, p = 0.001), whereas conservative management alone was more frequently successful in the EV (−) group (89.3% vs. 43.5%, p = 0.001). The EV (+) group showed higher rates of massive blood loss (> 2000 mL, 3.6% vs. 34.8%, p = 0.009), longer hospital stays (4.61 ± 2.61 vs. 6.88 ± 3.78 days, p = 0.034), and more frequent intensive care unit (ICU) admission (10.7% vs. 34.8%, p = 0.039). Patients in the EV (+) group had higher transfusion requirements (p < 0.005) and increased rates of disseminated intravascular coagulation (7.1% vs. 30.4%, p = 0.032). Conclusions: The presence of EV on CE-CT in PPH was associated with more severe clinical features, including greater transfusion requirements, increased rates of surgical intervention, ICU admission, and disseminated intravascular coagulation (DIC). Additionally, a higher proportion of patients with EV had a shock index ≥ 1.0, indicating early hemodynamic compromise.

  • Open Access

    Comparison of Surgical Outcomes Between Single-Port Access Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study

    by Suk Hwan Hyun, Ji Geun Yoo, Ye Won Jung, Won Kyo Shin, Soo Youn Song, Jae Sung Choi, Young Bok Ko, Mina Lee, Byung Hun Kang, Mia Park, et al.

    Background/Objectives: To compare the outcomes of single-port access laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases, we retrospectively analyzed clinical data from 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023. Methods: Of these 367 patients, 197 underwent SPALS, whereas 170 underwent SSRS. The SPALS group comprised 87 patients who underwent hysterectomy; 107, adnexal surgery (cystectomy: 44, adnexectomy: 63); and 1 myomectomy. The SSRS group included 68 patients who underwent myomectomy; 61, adnexal surgery (cystectomy: 52, adnexectomy: 9); 35, hysterectomy, and 4, sacrocolpopexy. Results: Both surgical techniques were successful, with no patients requiring open surgery. No significant differences were observed in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had a younger age (39.8 ± 9.5 vs. 44.5 ± 12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1 ± 65.9 vs. 57.1 ± 27.3 min, p = 0.001), gas passing time (39.4 ± 15.37 vs. 30.4 ± 13.5 h, p = 0.001), and hospital length of stay (4.26 ± 1.02 vs. 4.02 ± 0.8 days, p = 0.012) were significantly longer in the SSRS group. However, no significant differences were found between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower-parity patients tend to undergo SSRS rather than SPALS, with SSRS primarily performed for myomectomy and complex adnexal surgery. However, operation time and gas passing time were significantly longer in the SSRS group.


  • Open Access

    Comparison of Surgical Outcomes Between Single-Port Assess Laparoscopic and Single-Site Robotic Surgery in Benign Gynecologic Diseases: A Single-Center Cohort Study

    by Suk Hwan Hyun, Ji Geun Yoo, Ye Won Jung, Won Kyo Shin, Soo Youn Song, Jae Sung Choi, Young Bok Ko, Mina Lee, Byung Hun Kang, Mia Park, et al.

    Background/Objectives: To compare the outcomes of single-port assessment laparoscopic surgery (SPALS) and single-site robotic surgery (SSRS) for benign gynecological diseases. Methods: The clinical data of 367 patients who underwent gynecologic surgery at Sejong Chungnam National University Hospital from October 2020 to December 2023 were analyzed retrospectively. Of these 367 patients, 197 received SPALS while 170 underwent SSRS. The SPALS group comprise 87 hysterectomies, 107 adnexal surgeries (44 cystectomies, 63 adnexectomies) and 1 myomectomy. The SSRS group includes 68 myomectomies, 61 adnexal surgeries (52 cystectomies, 9 adnexectomies), 35 hysterectomies, and 4 sacrocolpopexies. Results: The results showed that both surgical techniques were successful, and no patients underwent open surgery. There were no significant differences in the baseline characteristics between the two groups. Compared with the SPALS group, the SSRS group had younger age (39.8±9.5 vs 44.5±12.3 years, p = 0.001). Severe intra-abdominal adhesions were more frequently observed in the SSRS group (p = 0.004). Operation time (118.1±65.9 vs 57.1±27.3 min, p = 0.001) and gas passing time (39.4±15.37 vs 30.4±13.5 hours, p = 0.001) were found to be longer, along with more hospital days (4.26±1.02 vs 4.02±0.8 days, p = 0.012), in SSRS group. However, there were no significant differences between the two groups in terms of intraoperative blood loss, intraoperative complications, or readmission rates. Conclusions: SSRS offers a feasible and promising approach for treating gynecological benign diseases. Younger and lower parity patients tend to have SSRS, compare to SPALS, and SSRS was mainly used for myomectomy and complex adnexal surgery. However, operation time and gas passing time were found to be longer in SSRS group.

  • Top Cited Papers
    Open Access

    Endometriosis-Related Chronic Pelvic Pain

    by Soo Youn Song, Ye Won Jung, WonKyo Shin, Mia Park, Geon Woo Lee, Soohwa Jeong, Sukjeong An, Kyoungmin Kim, Young Bok Ko, Ki Hwan Lee, et al.

    Endometriosis, which is the presence of endometrial stroma and glands outside the uterus, is one of the most frequently diagnosed gynecologic diseases in reproductive women. Patients with endometriosis suffer from various pain symptoms such as dysmenorrhea, dyspareunia, and chronic pelvic pain. The pathophysiology for chronic pain in patients with endometriosis has not been fully understood. Altered inflammatory responses have been shown to contribute to pain symptoms. Increased secretion of cytokines, angiogenic factors, and nerve growth factors has been suggested to increase pain. Also, altered distribution of nerve fibers may also contribute to chronic pain. Aside from local contributing factors, sensitization of the nervous system is also important in understanding persistent pain in endometriosis. Peripheral sensitization as well as central sensitization have been identified in patients with endometriosis. These sensitizations of the nervous system can also explain increased incidence of comorbidities related to pain such as irritable bowel disease, bladder pain syndrome, and vulvodynia in patients with endometriosis. In conclusion, there are various possible mechanisms behind pain in patients with endometriosis, and understanding these mechanisms can help clinicians understand the nature of the pain symptoms and decide on treatments for endometriosis-related pain symptoms.


  • Open Access

    Ovarian Function in Patients Who Underwent Opportunistic Bilateral Salpingectomy during Hysterectomy

    by Soo Youn Song, Ye Won Jung, Jing Hong Min, Wonkyo Shin, Mia Park, Heon Jong Yoo

    Objective(s): To provide additional data and to inform all women at average risk of ovarina cancer, undergoing a benign gynecological laparoscopic procedure about the Pro’s and the Con’s of opportunistic bilateral salpingectomy (OBS). Mechanism: Risk reducing salpingo-oophorectomy to prevent epithelial ovarian cancer (EOC) is associated with decreased quality of life and increased overall mortality. OBS has emerged as a primary prevention of ovarian cancer through a paradigm shift in which fallopian tubes are often the cause of ovarian cancer rather than the ovaries themselves. Findings in Brief: Causal relationship of salpingectomy and reduced risk of ovarian cancer has not been proven yet. There are several population-based studies that showed bilateral salpingectomy reduced risk of EOC by 42–67%, but there also is a study that suggest increased risk of ovarian cancer after salpingectomy. As for risk of surgical complications, several cohort studies have demonstrated that there was no increase in rates of hospital readmission, blood transfusion, day of hospital stay. However, recent meta-analysis stated that there were insufficient data to assess any difference in both intraoperative and postoperative complication rates. The procedure of salpingectomy can disrupt blood supply to the ovary. Data of reproductive outcome after assisted reproductive technologies such as in vitro fertilization and embryo transfer (IVF-ET) are conflicting. Some studies suggest that salpingectomy did not compromise the outcome of IVF-ET, but other studies found that salpingectomy may lead to decreased ovarian reserve after salpingectomy. For patients who do not wish fertility, data on the effect of OBS during hysterectomy suggest that changes in serum ovarian reserve markers were not different between OBS group and control group. Conclusions: Bilateral salpingectomy should be considered at the time of abdominal or pelvic for women at average risk of ovarian cancer. However, physicians should discuss the protective benefit of bilateral salpingectomy against ovarian cancer and controversial data on ovarian reserve.

  • Open Access

    The efficacy of gonadotropin-releasing hormone agonist treatment before hysteroscopic myomectomy for large-sized submucosal leiomyoma

    by Mia Park, Min Soon Song, Byung Hun Kang, Soo Youn Song, Geon Woo Lee, Ye Won Jung, Won Kyo Shin, Young Bok Ko, Ki Hwan Lee, Heon Jong Yoo

    To evaluate the efficacy and safety of a gonadotropin-releasing hormone (GnRH) agonist for treating large-sized submucosal leiomyoma before hysteroscopic myomectomy. The data were retrospectively collected from patients who underwent a hysteroscopic myomectomy for a submucosal leiomyoma >3.5 cm in size from January 2009 to December 2018. The patients were divided into the GnRH group and the control group according to whether they were pretreated before surgery. A total of 61 patients were included in the study, 31 in the GnRH agonist group and 30 in the control group. At diagnosis, the maximum leiomyoma diameter was similar between the 2 groups (4.67 ± 0.6 cm in the GnRH agonist group vs 3.82 ± 0.6 cm in the control group, P = .061). After pretreatment with the GnRH agonist, the maximum diameter was significantly smaller in the GnRH agonist group compared to the control group (3.82 ± 0.6 vs 4.33 ± 0.8 cm, respectively, P = .004). The leiomyoma volume in the GnRH agonist group decreased by 55.6%, from 41.68 ± 15.7 to 23.19 ± 10.4 cm3, which led to significant differences in leiomyoma volume between the 2 groups (23.19 ± 10.4 cm3 in the GnRH agonist group vs 33.22 ± 24.7 cm3 in the control group, P = .042). The GnRH agonist group showed a shorter operation time (37.7 vs 43.9 minutes, P = .040) and less uterine distention media was used (6800 vs 9373.3 mL, P = .037) compared to the control group. Postoperative complications such as estimated blood loss, remnant leiomyoma, and recurrence were similar between the 2 groups. Treatment with a GnRH agonist before hysteroscopic myomectomy for large submucosal leiomyoma might decrease the volume of the leiomyoma, reduce operation time, and the amount of uterine-distension media used without surgical complications.